{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:17:27Z","timestamp":1761218247529},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to impaired cortisol biosynthesis. Treatment includes glucocorticoid supplementation. We studied the specific metabolomics signatures in CAH patients using two different algorithms. Methods. In a case-control study of CAH patients matched on sex and age with healthy control subjects, two metabolomic analyses were performed: one using MetaboDiff, a validated differential metabolomic analysis tool and the other, using Predomics, a novel machine-learning algorithm. Results. 168 participants were included (84 CAH patients). There was no correlation between plasma cortisol levels during glucocorticoid supplementation and metabolites in CAH patients. Indoleamine 2,3-dioxygenase enzyme activity was correlated with ACTH (rho coefficient\u2009=\u2009\u22120.25, p-value = 0.02), in CAH patients but not in controls subjects. Overall, 33 metabolites were significantly altered in CAH patients. Main changes came from: purine and pyrimidine metabolites, branched aminoacids, tricarboxylic acid cycle metabolites and associated pathways (urea, glucose, pentose phosphates). MetaboDiff identified 2 modules that were significantly different between both groups: aminosugar metabolism and purine metabolism. Predomics found several interpretable models which accurately discriminated the two groups (accuracy of 0.86 and AUROC of 0.9). Conclusion. CAH patients and healthy control subjects exhibit significant differences in plasma metabolomes, which may be explained by glucocorticoid supplementation.<\/jats:p>","DOI":"10.1038\/s41598-020-65897-y","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T10:03:14Z","timestamp":1591005794000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of congenital adrenal hyperplasia treated by glucocorticoids on plasma metabolome: a machine-learning-based analysis"],"prefix":"10.1038","volume":"10","author":[{"given":"Lee S.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edi","family":"Prifti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Ichou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Leban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Touraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe-Elie","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bachelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"65897_CR1","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/s0140-6736(17)31431-9","volume":"390","author":"D El-Maouche","year":"2017","unstructured":"El-Maouche, D., Arlt, W. & Merke, D. P. Congenital adrenal hyperplasia. Lancet (London, England) 390, 2194\u20132210, https:\/\/doi.org\/10.1016\/s0140-6736(17)31431-9 (2017).","journal-title":"Lancet (London, England)"},{"key":"65897_CR2","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1530\/eje-16-0888","volume":"176","author":"A Bachelot","year":"2017","unstructured":"Bachelot, A., Grouthier, V., Courtillot, C., Dulon, J. & Touraine, P. MANAGEMENT OF ENDOCRINE DISEASE: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update on the management of adult patients and prenatal treatment. European journal of endocrinology 176, R167\u2013r181, https:\/\/doi.org\/10.1530\/eje-16-0888 (2017).","journal-title":"European journal of endocrinology"},{"key":"65897_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s40265-014-0282-9","volume":"74","author":"L Fardet","year":"2014","unstructured":"Fardet, L. & F\u00e8ve, B. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs 74, 1731\u20131745, https:\/\/doi.org\/10.1007\/s40265-014-0282-9 (2014).","journal-title":"Drugs"},{"key":"65897_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray, M., Abu Samra, K., Ebrahimiadib, N., Meese, H. & Foster, C. S. Long-term side effects of glucocorticoids. Expert Opin Drug Saf 15, 457\u2013465, https:\/\/doi.org\/10.1517\/14740338.2016.1140743 (2016).","journal-title":"Expert Opin Drug Saf"},{"key":"65897_CR5","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"Falhammar, H. et al. Increased Mortality in Patients With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The Journal of Clinical Endocrinology & Metabolism 99, E2715\u2013E2721, https:\/\/doi.org\/10.1210\/jc.2014-2957 (2014).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"65897_CR6","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/jc.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"Falhammar, H. et al. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. The Journal of clinical endocrinology and metabolism 100, 3520\u20133528, https:\/\/doi.org\/10.1210\/jc.2015-2093 (2015).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"65897_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.beem.2014.11.002","volume":"29","author":"N Reisch","year":"2015","unstructured":"Reisch, N. Substitution therapy in adult patients with congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 29, 33\u201345, https:\/\/doi.org\/10.1016\/j.beem.2014.11.002 (2015).","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"65897_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/clpt.2013.217","volume":"95","author":"R Kaddurah-Daouk","year":"2014","unstructured":"Kaddurah-Daouk, R. & Weinshilboum, R. M. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clinical pharmacology and therapeutics 95, 154\u2013167, https:\/\/doi.org\/10.1038\/clpt.2013.217 (2014).","journal-title":"Clinical pharmacology and therapeutics"},{"key":"65897_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/cpt.134","volume":"98","author":"R Kaddurah-Daouk","year":"2015","unstructured":"Kaddurah-Daouk, R. & Weinshilboum, R. Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine. Clinical pharmacology and therapeutics 98, 71\u201375, https:\/\/doi.org\/10.1002\/cpt.134 (2015).","journal-title":"Clinical pharmacology and therapeutics"},{"key":"65897_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17220-5","volume":"7","author":"MA Alwashih","year":"2017","unstructured":"Alwashih, M. A. et al. Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia. Sci Rep 7, 17092, https:\/\/doi.org\/10.1038\/s41598-017-17220-5 (2017).","journal-title":"Sci Rep"},{"key":"65897_CR11","doi-asserted-by":"publisher","unstructured":"Prifti, E. et al. Interpretable and accurate prediction models for metagenomics data. GigaScience 9, https:\/\/doi.org\/10.1093\/gigascience\/giaa010 (2020).","DOI":"10.1093\/gigascience\/giaa010"},{"key":"65897_CR12","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1093\/bioinformatics\/bty344","volume":"34","author":"A Mock","year":"2018","unstructured":"Mock, A. et al. MetaboDiff: an R package for differential metabolomic analysis. Bioinformatics (Oxford, England) 34, 3417\u20133418, https:\/\/doi.org\/10.1093\/bioinformatics\/bty344 (2018).","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"231\u2013240","key":"65897_CR13","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/j.echo.2017.10.017","volume":"31","author":"JE Salem","year":"2018","unstructured":"Salem, J. E. et al. Complex Association of Sex Hormones on Left Ventricular Systolic Function: Insight into Sexual Dimorphism. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography 31(231\u2013240), e231, https:\/\/doi.org\/10.1016\/j.echo.2017.10.017 (2018).","journal-title":"Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography"},{"key":"65897_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep15954","volume":"5","author":"N Bordag","year":"2015","unstructured":"Bordag, N. et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep 5, 15954, https:\/\/doi.org\/10.1038\/srep15954 (2015).","journal-title":"Sci Rep"},{"key":"65897_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.abb.2013.11.009","volume":"544","author":"J Geng","year":"2014","unstructured":"Geng, J. & Liu, A. Heme-dependent dioxygenases in tryptophan oxidation. Archives of biochemistry and biophysics 544, 18\u201326, https:\/\/doi.org\/10.1016\/j.abb.2013.11.009 (2014).","journal-title":"Archives of biochemistry and biophysics"},{"key":"65897_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14737175.2015.1049999","volume":"15","author":"I Davis","year":"2015","unstructured":"Davis, I. & Liu, A. What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics? Expert review of neurotherapeutics 15, 719\u2013721, https:\/\/doi.org\/10.1586\/14737175.2015.1049999 (2015).","journal-title":"Expert review of neurotherapeutics"},{"key":"65897_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.mop.0000236395.71956.5c","volume":"18","author":"CE Fluck","year":"2006","unstructured":"Fluck, C. E. & Miller, W. L. P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia. Current opinion in pediatrics 18, 435\u2013441, https:\/\/doi.org\/10.1097\/01.mop.0000236395.71956.5c (2006).","journal-title":"Current opinion in pediatrics"},{"key":"65897_CR18","first-page":"305","volume":"34","author":"M Pizzichini","year":"1985","unstructured":"Pizzichini, M., Di Stefano, A. & Marinello, E. The regulation of purine ribonucleotide biosynthesis by glucocorticoid hormones. The Italian journal of biochemistry 34, 305\u2013312 (1985).","journal-title":"The Italian journal of biochemistry"},{"key":"65897_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/eje-19-0379","volume":"181","author":"LS Nguyen","year":"2019","unstructured":"Nguyen, L. S. et al. Influence of hormones on the immunotolerogenic molecule HLA-G: a cross-sectional study in patients with congenital adrenal hyperplasia. European journal of endocrinology 181, 481\u2013488, https:\/\/doi.org\/10.1530\/eje-19-0379 (2019).","journal-title":"European journal of endocrinology"},{"key":"65897_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/HJH.0000000000001850","volume":"37","author":"D Rosenbaum","year":"2019","unstructured":"Rosenbaum, D. et al. Early central blood pressure elevation in adult patients with 21-hydroxylase deficiency. J Hypertens 37, 175\u2013181, https:\/\/doi.org\/10.1097\/HJH.0000000000001850 (2019).","journal-title":"J Hypertens"},{"key":"65897_CR21","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/bib\/bbx060","volume":"19","author":"I Garali","year":"2018","unstructured":"Garali, I. et al. A strategy for multimodal data integration: application to biomarkers identification in spinocerebellar ataxia. Briefings in bioinformatics 19, 1356\u20131369, https:\/\/doi.org\/10.1093\/bib\/bbx060 (2018).","journal-title":"Briefings in bioinformatics"},{"key":"65897_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/bioinformatics\/btu813","volume":"31","author":"F Giacomoni","year":"2015","unstructured":"Giacomoni, F. et al. Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics. Bioinformatics (Oxford, England) 31, 1493\u20131495, https:\/\/doi.org\/10.1093\/bioinformatics\/btu813 (2015).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"65897_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith, C. A., Want, E. J., O\u2019Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical chemistry 78, 779\u2013787, https:\/\/doi.org\/10.1021\/ac051437y (2006).","journal-title":"Analytical chemistry"},{"key":"65897_CR24","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1021\/ac300698c","volume":"84","author":"R Tautenhahn","year":"2012","unstructured":"Tautenhahn, R., Patti, G. J., Rinehart, D. & Siuzdak, G. XCMS Online: a web-based platform to process untargeted metabolomic data. Analytical chemistry 84, 5035\u20135039, https:\/\/doi.org\/10.1021\/ac300698c (2012).","journal-title":"Analytical chemistry"},{"key":"65897_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nature protocols 5, 1005\u20131018, https:\/\/doi.org\/10.1038\/nprot.2010.50 (2010).","journal-title":"Nature protocols"},{"key":"65897_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B. et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature protocols 6, 1060\u20131083, https:\/\/doi.org\/10.1038\/nprot.2011.335 (2011).","journal-title":"Nature protocols"},{"key":"65897_CR27","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.4155\/bio.12.204","volume":"4","author":"WB Dunn","year":"2012","unstructured":"Dunn, W. B., Wilson, I. D., Nicholls, A. W. & Broadhurst, D. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans. Bioanalysis 4, 2249\u20132264, https:\/\/doi.org\/10.4155\/bio.12.204 (2012).","journal-title":"Bioanalysis"},{"key":"65897_CR28","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1021\/ac201065j","volume":"83","author":"KA Veselkov","year":"2011","unstructured":"Veselkov, K. A. et al. Optimized preprocessing of ultra-performance liquid chromatography\/mass spectrometry urinary metabolic profiles for improved information recovery. Analytical chemistry 83, 5864\u20135872, https:\/\/doi.org\/10.1021\/ac201065j (2011).","journal-title":"Analytical chemistry"},{"key":"65897_CR29","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1093\/bioinformatics\/bty344","volume":"34","author":"A Mock","year":"2018","unstructured":"Mock, A. et al. MetaboDiff: an R package for differential metabolomic analysis. Bioinformatics (Oxford, England) 34, 3417\u20133418, https:\/\/doi.org\/10.1093\/bioinformatics\/bty344 (2018).","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"Suppl 1","key":"65897_CR30","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.s96","volume":"18","author":"W Huber","year":"2002","unstructured":"Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (Oxford, England) 18(Suppl 1), S96\u2013104, https:\/\/doi.org\/10.1093\/bioinformatics\/18.suppl_1.s96 (2002).","journal-title":"Bioinformatics (Oxford, England)"},{"key":"65897_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289\u2013300 (1995).","journal-title":"Series B (Methodological)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65897-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65897-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65897-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:04:17Z","timestamp":1670328257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65897-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65897"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65897-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"8 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8859"}}